Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke

NCT07483281 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Human Urinary Kallidinogenase
OTHER: Clinical Routine Treatment

Sponsor

China-Japan Union Hospital